WuXi PharmaTech Financial Statements
WuXi PharmaTech Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
WuXi PharmaTech Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 135.2 | 69.9 | 33.8 |
| Gross Profit ($ mil.) | 62.8 | 34.3 | 18.3 |
| Operating Income ($ mil.) | 30.2 | 10.1 | 8.7 |
| Total Net Income ($ mil.) | 33.9 | 8.9 | 6.1 |
| Diluted EPS (Net Income) | -- | -- | -- |
WuXi PharmaTech Stock Quote & Chart
10/10/08 15:04:57 EST •
NYSE •
6.67
•
 -0.5600
•
-7.7455 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
WuXi PharmaTech Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 63.71 | 3.46 | 1.50 |
| Price/Earnings Ratio | -- | 15.43 | 15.53 |
| Price/Book Ratio | 34.26 | 2.88 | 1.48 |
| Price/Cash Flow Ratio | 132.05 | 12.60 | 9.53 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed WuXi PharmaTech Financial Ratios
WuXi PharmaTech Competitive Intelligence
| Charles River Laboratories | Covance | ICON | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,230.6 | 1,631.5 | 630.7 |
| Employees | 8,500 | 8,700 | 5,610 |
| Market Cap ($ mil.) | 4,609.5 | 6,111.9 | -- |
Competitive Landscape
